AZASAN Trademark

Trademark Overview

On Monday, March 18, 2024, a trademark application was filed for AZASAN with the United States Patent and Trademark Office. The USPTO has given the AZASAN trademark a serial number of 98454923. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Wednesday, March 19, 2025. This trademark is owned by Alcami Carolinas Corporation. The AZASAN trademark is filed in the Pharmaceutical Products category with the following description:

azathioprine-based pharmaceuticals used as immunosuppressants and antirheumatic drugs
azasan

General Information

Serial Number98454923
Word MarkAZASAN
Filing DateMonday, March 18, 2024
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateWednesday, March 19, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 8, 2025

Trademark Statements

Goods and Servicesazathioprine-based pharmaceuticals used as immunosuppressants and antirheumatic drugs

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, March 18, 2024
Primary Code005
First Use Anywhere DateThursday, February 6, 2003
First Use In Commerce DateThursday, February 6, 2003

Trademark Owner History

Party NameBAUSCH HEALTH IRELAND LIMITED
Party Type11 - New Owner Before Publication
Legal Entity Type99 - Other
AddressDUBLIN 24
IE
Party NameAlcami Carolinas Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWilmington, NC 28405

Trademark Events

Event DateEvent Description
Monday, March 18, 2024NEW APPLICATION ENTERED
Thursday, May 23, 2024TEAS VOLUNTARY AMENDMENT RECEIVED
Tuesday, April 2, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, September 11, 2024AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Thursday, September 26, 2024ASSIGNED TO EXAMINER
Tuesday, October 1, 2024NON-FINAL ACTION WRITTEN
Tuesday, October 1, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, October 1, 2024NON-FINAL ACTION E-MAILED
Friday, January 17, 2025ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Friday, January 17, 2025ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Tuesday, March 11, 2025PETITION TO REVIVE-GRANTED
Tuesday, March 11, 2025NOTICE OF REVIVAL - E-MAILED
Tuesday, March 11, 2025TEAS PETITION TO REVIVE RECEIVED
Tuesday, March 11, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, March 11, 2025APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, March 11, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, March 11, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, March 11, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, March 11, 2025TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, March 11, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, March 11, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, March 13, 2025APPROVED FOR PUB - PRINCIPAL REGISTER

Related Keywords

azasan antirheumatic drugs immunosuppressants used based pharmaceuticals azathioprine